KB
MDT icon

Kimelman & Baird’s Medtronic MDT Stock Holding History

Kimelman & Baird’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Sell
163,671
-6,219
-4% -$502K 0.94% 32
2026
Q1 		$14.7M Buy
169,890
+500
+0.3% +$47.9K 1.21% 29
2025
Q4 		$16.3M Buy
169,390
+421
+0.2% +$40.9K 1.25% 28
2025
Q3 		$16.1M Buy
168,969
+29,978
+22% +$2.76M 1.26% 26
2025
Q2 		$12.1M Buy
138,991
+132,790
+2,141% +$11.3M 0.99% 30
2025
Q1 		$557K Buy
6,201
+6,010
+3,147% +$538K 0.05% 87
2024
Q4 		$15.3K Hold
191
– – ﹤0.01% 248
2024
Q3 		$17.2K Hold
191
– – ﹤0.01% 243
2024
Q2 		$15K Buy
+191
New +$15.7K ﹤0.01% 252

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Kimelman & Baird's MDT Position: Q2 2026 in Review

Kimelman & Baird reduced its Medtronic (MDT) stake by 3.7% in Q2 2026, selling an estimated $502K and leaving 163,671 shares worth $12.8M. The position accounts for 0.94% of the portfolio, ranked #32.

Kimelman & Baird first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $16.3M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Kimelman & Baird held 163,671 shares of Medtronic worth $12.8M as of Q2 2026.
  • Kimelman & Baird sold 6,219 Medtronic shares in Q2 2026, an estimated $502K.
  • Medtronic made up 0.94% of Kimelman & Baird's portfolio in Q2 2026, its #32 holding.
  • Kimelman & Baird first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Kimelman & Baird's Medtronic position peaked at $16.3M in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.